BI Bets On Gene Therapy To Treat All Cystic Fibrosis Patients
Entering Market Dominated By Vertex
Executive Summary
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium and Oxford BioMedica aim to get their CFTR gene therapy into the clinic soon, confident it could offer a long-lasting option for patients with cystic fibrosis.